Skip to main content

Table 1 Baseline characteristics of patients

From: Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: multicenter randomized controlled clinical trial (phase I/II)

  Control BM-MSCs
Low-dose High-dose
N 10 10 10
Age (years) 60.3 (55.1, 61.1) 65.9 (59.5, 70.6) 57.8 (55.0, 60.8)
Males, n (%) 7 (70) 4 (40) 8 (80)
BMI (kg/m2) 29.6 (26.2, 30.8) 27.1 (24.4, 31.2) 28.5 (25.8, 31.0)
Time since OA diagnosis (years) 6 (2, 8) 9 (4, 12) 10 (7, 15)
K-L 2, n (%) 4 (40) 1 (10) 3 (30)
K-L 3, n (%) 2 (20) 2 (20) 3 (30)
K-L 4, n (%) 4 (40) 7 (70) 4 (40)
  1. Unless specified, data are presented as median [interquartile range (IQR)]. OA osteoarthritis, K–L Kellgren and Lawrence grading scale of severity of knee OA